ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS

ANTINEOPLASTIC AGENTS

MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES

HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors

trastuzumab

Temporary cessation of marketing of the medicinal product.

Informacije o zdravilu

Amgen Europe B.V.

Potrditev podatkov za CP zdravila (modro okence)

KANJINTI 150 mg prašek za koncentrat za raztopino za infundiranje

Intravenska uporaba

Accessibility Statement

Advanced search

Name

Change history of medication data

Drug comparison

Composition and organoleptic properties

Changes to Terms

General

Limitation of Liability

Links to Other Sites

Terms of Use

Use of the Website

SmPC version comparison

SmPC chapters

Documents

Downloads

Pre-prepared medicine lists

Drug status

Filters

1. About the National Drug Registry

2. About the web application

3.1. Home page

3.2. Searching for data

3.3. Pre-prepared lists

3.4. Displaying the list of medicines

3.5. Displaying detailed information

3. Using the application

User Guide

National Drug Registry

News

Legend

Medicine name

Interchangeable medicines

The requested content does not exist or is no longer available. Please check the address or return to the home page.

Page not found

Privacy Policy

Search

Therapeutic group of medicines

Predpisovanje in izdaja zdravila je le na recept, zdravilo pa se uporablja samo v bolnišnicah.

Vial

KANJINTI 150 mg prašek za koncentrat za raztopino za infundiranje škatla z 1 vialo

Safety features are present